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1. SUMMARY 
The use of lasers in dermatology 
Kristina Žužul 
 
 This graduate thesis explains the basic laser principles and provides an overview of 
indications for laser treatment in dermatology. The term laser is an acronym for light 
amplification by the stimulated emission of radiation. Since the development of first laser by 
Maiman and the introduction of theory of selective photothermolysis in 1980 by Anderson 
and Parish, it gained widespread acceptance in dermatology and is now used for the treatment 
of numerous cutaneous conditions including pigmented and vascular lesions, tattoos, scars, 
unwanted hair, and aging skin. When a laser is used on the skin, the light can be absorbed, 
reflected, transmitted or scattered. Once laser energy is absorbed, the possible effects are 
photochemical, photothermal and photoacoustic. Due to different clinical applications of 
wavelengths and pulse durations, the choice of laser should be based upon the individual 
absorption characteristics of the target chromophore. 
 Pigment specific lasers target melanin and can successfully lighten or eradicate a 
variety of benign epidermal and dermal pigmented lesions and tattoos with minimal risk of 
unwanted effects. Nowadays, Q-switched lasers are the first choice for most pigmented 
lesions, but continuous wave and quasi-continuous wave lasers can also be effective if used 
properly by experienced operator. Laser systems for hair removal include alexandrite (755 
nm), diode (800 and 810 nm) and Nd:YAG (1064nm). Vascular specific laser systems target 
intravascular oxyhemoglobin to destroy congenital and acquired vascular lesions. Lasers used 
for this purpose include PDL (585 nm), long pulsed-dye laser (595 nm), KTP (532 nm) and 
the Nd:YAG (1064 nm). CO2 and Er:YAG lasers were traditionally used for laser skin 
resurfacing, but one of the newest trends in dermatology has been development of nonablative 
and fractional laser systems whose advantages are less side effects and decreased downtime. 
 Of outmost importance is the safety of both patient and the operating room personnel 
during laser irradiation. Key safety measures include education, eye, skin and teeth protection, 
as well as protection from plume, fire and electrical hazards. 
Keywords: laser, dermatology, indications, safety measures
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2. INTRODUCTION 
 
Laser therapy is currently one of the most rapidly evolving areas of medical 
technology, and the developments of laser technology from the cradle of modern physics in 
1900 by Planck to its latest medical boundaries is an exciting example of how basic physics 
finds its way into the clinical practice. Until 1900, the study of light was limited to examining 
its behavior. By the time scientists had identified light sources, but they didn't know how light 
was generated. In 1900, Planck defined a relation E=hf, but it took until Albert Einstein in 
1917 postulated the phenomenon of extremely focused light beams in his publication on 
quantum theory. 
During World War II, scientists became engaged with radar equipment and developed interest 
in the spectral part of microwaves. In 1954, Robert H. Dicke proposed the “optical bomb” in 
the US, in which a short excitation pulse would produce an inverted population, which would 
then generate an intense burst of spontaneous emission. In 1956, he filed a patent using a pair 
of parallel mirrors, forming Fabry-Perot interferometer, as a resonant optical cavity. At the 
end, this led to production of a “maser” in 1954 by Townes at the Columbia University. The 
acronym “maser” stands for Microwave Amplification by Stimulated Emission of Radiation. 
After all, it took 43 years after Einstein’s first theories, until Maiman developed a laser in 
1960. He introduced a ruby laser as a first commercially available laser, and consequently set 
Einstein’s theory into practice. The acronym LASER was already created by Gould, and 
stands for Light Amplification by Stimulated Emission of Radiation (Gross AJ and Herrmann 
TRW 2007). In the first true laser, microwave energy was amplified by a ruby crystal to 
create a beam of red light travelling in a phase at a wavelength of 694 nm. The ruby laser was 
followed shortly by the development of other solid laser systems such as the Nd:YAG 1064 
nm. Gaseous lasing mediums, including argon, helium-neon and CO2 lasers, offered an 
alternative to solid glass rods (Houk LD and Humphreys T 2007). 
The laser’s first medical use was in ophthalmology to repair detached retinas by means 
of “spot welding”. Their use in dermatology started by Goldman, who was the first physician 
to exploit the properties of the ruby laser to treat tattoos (Goldman et al. 1964). Early lasers, 
such as the argon and CO2 systems, emitted an uninterrupted beam of light, which in addition 
to destroying the desired target, also exposed the surrounding healthy tissue to laser energy 
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for prolonged periods, causing collateral damage with unacceptably high rates of hypertrophic 
scarring and pigment alteration. In order to limit the amount of this nonselective thermal 
damage, the continuous wave lasers were later made “discontinuous” using a mechanical 
shutter to interrupt the beam of light (Houk LD and Humphreys T 2007). 
Later, advances in laser technology have progressed rapidly, resulting in development of new 
laser systems with better therapeutic results and low risk of adverse effects (Tanzi El et al. 
2003). In the 1960s, the emphasis was on the mode locking of flashlamp-pumped ruby, 
neodymium-glass and organic dye lasers; in the 1970s and 1980s there were major 
developments in the generation of sub-picosecond and femtosecond pulses from continuous 
wave organic dye lasers; whereas in 1980s and 1990s there were concerted efforts in the 
generation of femtosecond pulses in the near-infrared spectral region (Lipozenčić J and 
Bukvić Mokos Z 2010). 
For many years following the initial studies of the effects of lasers on the skin, the use 
of lasers was limited to nonselective coagulation and vaporization of tissue. It was with the 
flashlamp-pumped pulsed dye laser (PDL) in the early 1980s that Anderson and Parrish 
developed the theory of selective photothermolysis that revolutionized the practice of 
cutaneous laser surgery (Anderson RR and Parrish JA 1983). They explained how site-
specific, thermally mediated injury of microscopic targets can be achieved without thermal 
injury of surrounding tissue. The majority of subsequent developments in laser technology for 
cutaneous disorders have been based upon this theory. 
Laser technology has been further refined to perfect selective delivery to a specific 
target and minimize unwanted adverse effects. Cooling technology limits inadvertent damage 
to tissues adjacent to targeted sites, allowing higher levels of light energy to be directed 
towards the target.  
Examination of recent trends in laser treatment modalities reveals that longer 
wavelengths are being paired with longer pulse durations to target deeper structures and 
minimize collateral damage. This has been particularly true in the case of vascular lasers 
designed to target larger vessels and produce less purpura. Also, there is a quest for 
photorejuvenation without “downtime”, which resulted in emergence of nonablative laser 
systems focused on dermal remodeling (Houk LD and Humphreys T 2007). 
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3. GENERAL PRINCIPLES AND PHYSICS OF LASER 
 
3.1. Laser principles 
Laser is a device based on the luminance stimulated by photons of characteristic 
frequency with unique features. Laser light is monochromatic (composed of single 
wavelength), parallel (even in long distance, and enables precise tissue destruction), coherent 
(all the waves travel in phase) and high energy (Brnjas Kraljević J 2001). 
The first principle of Einstein’s quantum theory comprehends that light travels in 
packets of energy known as photons. The second principle implies that most atoms or 
molecules exist in a ground or low energy state (E0) relative to their energy levels. However, a 
small percentage of atoms naturally occur at any given time at a higher, discrete energy level 
(E
1
, E
2
, E
n
). It is possible by adding thermal, electric, or optical energy to atoms in the ground 
state to convert the majority of E0 atoms to higher energy levels. The energy is then released 
spontaneously in the form of photons or electromagnetic waves to return to the ground state. 
Einstein also discovered that, when a photon of light energy of the same wavelength strikes an 
excited atom (E
n
), that photon and the photon of light that is released are discharged 
simultaneously and therefore will be identical in frequency and phase. This is the concept of 
simulated emission used in the creation of a laser (Gross AJ and Herrmann TRW 2007). 
Simultaneous emission is possible in systems with inversed population. It is crucial for the 
laser systems to possess metastable state, because that will assure simultaneous excitation of 
system with inversed population and continuous simultaneous emission.  
Each laser system is composed of the following primary components: the laser 
medium which can be solid, liquid or gas, the optical cavity which surrounds the laser 
medium, the power supply or pump which excites the atoms of laser medium, and a delivery 
system which delivers light to target with precision. 
One laser pulse of 1µs duration emits the beam of energy 10 mJ. With the beam 
diameter of 10 µm, the density is 1014 Wm-2, which is 1011 times higher power density than 
the density of the Sun radiation on the Earth surface. It is also important to emphasize that all 
the photons are of the same energy, which means that the same effects are achieved when 
interacting with tissues (Brnjas Kraljević J 2001). 
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3.2. Interaction with tissue 
Photon – tissue interactions include photochemical, photothermal or photoacoustic 
effect (Watanabe S et al. 1988). Photochemical events are more likely to occur with 
wavelengths less than 500 nm and can be seen with either short or long exposures of up to 
several hours. Thermal events are more likely to occur from visible or infrared radiation, and 
exposures may last from fractions of milliseconds to many seconds. Damage mechanisms 
dependent upon electric field strength, may occur after very short exposures of very high 
intensity (Watanabe S 2008).  
When the light of any wavelength or intensity hits the skin, four possible results ensue. 
The light can be directly reflected (usually in stratum corneum, which is the reason for 
wearing protective eyewear), scattered by collagen in the dermis, or transmitted through the 
dermis to the subcutaneous tissues. The light that results in actual work being done on the 
tissues is the light that is absorbed (Baumann L 2009). 
As compared to other treatment options, the use of lasers aims at a selective removal 
of diseased target structures with maximum sparing of uninvolved adjacent skin. Several 
features are unique and responsible in order to achieve this goal. Laser light is both coherent 
and monochromatic. Thus, light of a given wavelength can be focused, enabling the delivery 
of extremely high power densities to a given treatment spot. Depending on the absorption of 
the irradiated light energy in tissue and on the delivered power density, different effects can 
be obtained. Lasers can be used to coagulate, vaporize, cut or ablate the skin surface. They 
also can be employed for photostimulation (Kaufmann R 2006). Moreover, a given 
chromophore target can be destroyed by selective photothermolysis, a theory introduced by 
Anderson and Parish in 1983 (Anderson RR and Parrish JA 1983). This theory states that the 
selectivity of a laser for its target relies on the fact that different wavelengths of light will be 
absorbed by different chromophores in the skin. Since the three main chromophores in the 
skin – water, hemoglobin and melanin, have different wavelengths, it is possible to select a 
specific laser with a wavelength that will be absorbed by the chromophore which allows 
treating the target without damaging surrounding tissues. In order to achieve this, the pulse 
width should be sufficiently long to heat the tissue to the level of destruction, but not long 
enough for that heat to transfer out of the target to surrounding normal skin.  
5 
 
The duration of active lasing is termed “pulse width” or “pulse duration”. The ideal pulse 
duration for selective destruction of a target is determined by the size of the target. The time it 
takes for the target to dissipate two-thirds of its heat to surrounding tissue is directly 
proportional to its size. This is termed the thermal relaxation time. The pulse width should be 
equal or shorter than this thermal relaxation time in order to selectively destroy the target and 
not the normal surrounding tissue. Since lasers can emit light in a continuous fashion, in 
spurts, or in pulses, it is important to emphasize that the theory of selective photothermolysis 
only applies to pulsed laser systems, as continuous lasing results in bulk heating of tissue and 
hence little “selectivity” (Baumann L 2009). Two important laser parameters are irradiance 
and energy fluence. Energy is expressed in joules, while the power of laser is expressed in 
watts. Fluence is defined as energy per area and calculates the amount of laser energy 
delivered in a single pulse (J/cm
2
), and irradiance, also known as power density, determines 
the capacity of laser to incise, coagulate and vaporize tissue, with units in watts/cm
2
.  
By selecting a wavelength specific for the desired target chromophore and delivering 
that energy fast enough so that the chromophore’s relaxation time is not exceeded, thermal 
damage to nearby structures would be avoided. If the energy density (fluence) is sufficient to 
destroy the chromophore in this short window of time, therapeutic destruction could be 
maximized while minimizing thermal damage to the surrounding tissue (Houk LD and 
Humphreys T 2007). On the basis of these principles, laser parameters can be tailored to 
effect destruction of the tissue confined to microscopic sites of selective light absorption in 
the skin, such as blood cells and pigmented cells, with minimal collateral thermal damage 
(Anderson RR and Parrish JA 1983). Absorption and the amount of energy transfer per tissue 
volume mainly depend on the exposure spot size and wavelength of the laser used while the 
achievable power densities depend on the time in which a certain amount of energy is 
delivered to the tissue. That means that selectivity of laser light treatment can at least to some 
degree be achieved by choosing an appropriate laser light wavelength and spot size 
responsible for penetration depth (Anderson RR and Ross E 2000), and appropriate pulse 
duration responsible for the amount of heat diffusion. 
When the target tissue is beneath the epidermis, protection of the epidermis is 
achieved by cooling systems which are critical in several laser procedures including vessel 
destruction and laser hair removal. There are several modes of cooling used in lasers today, 
including cryogen cooling, contact, ice and direct cold air (Baumann L 2009) 
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4. PIGMENT SPECIFIC LASERS 
 
 The main advantage of laser therapy compared to conventional methods of treatment 
of pigmented lesions is in selective photothermolysis, which results in excellent cosmetic 
result with minimal risk of scarring. It is also necessary to select the proper laser according to 
the location of the pigment within the lesion. Before treating pigmented lesions, it is 
extremely important to make a correct diagnosis. In cases of initially misdiagnosed 
melanomas, laser therapy not only prevents appropriate and timely therapy but may also 
worsen the prognosis. In most cases prior the treatment, dermoscopy is indicated, and if there 
is any doubt whether the lesion is benign, biopsy for histologic evaluation is mandatory 
(Bukvić Mokos Z et al. 2010). 
 The first invented laser was also the first one to be used for pigment removal. The 
ruby laser is excellent for the removal of any pigment, but unfortunately due to inability to 
differentiate unwanted from normal pigment, it has been replaced by the longer-wavelength 
lasers. Taking into account that melanin absorbs light from 500 to 1100 nm, there are several 
lasers that can be used to treat pigmented lesions of the skin, divided in the two main groups: 
1) pulsed and quality switched (QS) lasers, 2) continuous wave (CW) and quasi-continuous 
wave lasers (Alster TS and Lupton JR 2001).  
Since melanosomes are very small and have very short thermal relaxation time (around 1 
millisecond), in order to selectively target melanin without harming the surrounding tissue, 
relaxation times equal or shorter than the thermal relaxation time of melanin should be used. 
Q-switched lasers have a mechanism that stores the generated energy and releases it as very 
short, intense pulses with the pulse width in the nanosecond range. This extremely short pulse 
duration makes Q-switched lasers ideal for selective destruction of melanin, without 
dissipation of heat from the target to the surrounding tissues. The most common Q-switched 
lasers used today are the Q-switched ruby (694 nm), Q-switched alexandrite (755 nm), Q-
switched Nd:YAG (1064 nm) and the frequency-doubled Nd:YAG (532 nm). Choosing which 
Q-switched laser to use largely depends on the color and depth of the lesion to be treated. 
Longer wavelengths are better for deeper pigment and pigment in dark-skinned patients, 
whereas shorter wavelengths are used in fair-skinned patients with superficial lesions 
(Baumann L 2009). 
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Continuous wave (CW) and quasi-continuous wave lasers emit a constant beam of 
light with pulse duration longer than thermal relaxation of melanosomes, which results in 
surrounding tissue injury. Since they are unable to deeply penetrate the skin due to their 
shorter wavelengths, they are mainly used for treatment of epidermal lesions (Wheeland 
2005). They remove the epidermal pigment by denuding the epidermis and destroying dermo-
epidermal junction. Argon laser (488/514 nm) is a continuous wave laser, while potassium 
titanyl phosphate KTP (532 nm), copper vapor (511 nm) and krypton (520 nm) are quasi-
continuous wave lasers which shutter the continuous wave beam into short segments 
producing interrupted emissions of constant beam. Nowadays, Q-switched lasers are the first 
choice for most pigmented lesions, but continuous wave and quasi-continuous wave lasers can 
also be effective if used properly by experienced operator (Wheeland RG 2005).  
Adverse effects of laser therapy include hyperpigmentation or hypopigmentation, 
more often present in dark-skinned patients. Due to possibility of developing post-
inflammatory hyperpigmentation when a higher epidermal melanin content is present, it is 
strongly recommended to avoid treating tanned patients or pre-treat with bleaching agents 
acting on pre-melanin synthesis (tretionin), melanin synthesis (hydroquinone, arbutin, vitamin 
C), or post-melanin synthesis (alpha hydroxy acid) (Baumann L 2009 & Bernstein EF 2007). 
 Pigmented lesions are categorized by location of pigment in three groups. Epidermal 
pigmented lesions include solar lentigines, ephelides, café au lait macules and seborrheic 
keratoses. Dermal lesions include melanocytic nevi, blue nevi, drug induced 
hyperpigmentation, and nevus of Ota and Ito. Some lesions exhibit both an epidermal and 
dermal component: Becker’s nevus, postinflammatory hyperpigmentations, melasma and 
nevus spilus (Stratigos AJ et al. 2000). 
 
4.1. Epidermal pigmented lesions 
4.1.1. Solar lentigines 
 Solar lentigines are benign, brownish lesions that occur on light exposed skin surfaces 
from age 30 onwards, as a sign of photoaging. The size varies from 0,2 to 2 cm, there is no 
bleaching during winter, and the number increases with advancing age. Although not 
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premalignant, they present a significant cosmetic problem, and show the best results to laser 
therapy among all pigmented lesions (Bukvić Mokos Z et al. 2006). 
Lasers used for treatment include Nd:Yag (532nm) laser, associated with purpura due to slight 
absorption by superficial melanin and dermal hemoglobin (Fitzpatrick RE et al. 1993 & Tan 
OT et al. 1992), Q-switched alexandrite (755 nm) laser, and QSRL (694 nm) which can cause 
hypopigmentation. Using QSRL laser, lentigines usually become 50% lighter after only one 
treatment, with lesions on the face being more responsive to treatment than those on the trunk 
or the extremities. Excellent results are accomplished after usually two to three laser sessions 
repeated in six to eight weeks interval (Bukvić Mokos Z et al. 2006).  
 
4.1.2. Ephelides 
Ephelides (freckles) are flat, round and tan spots that appear on a person’s skin, most 
commonly on the cheeks and nose, as well as the arms and upper shoulders. They are seen 
most often in the red-haired or blond person as sharply demarcated, light brown-ginger 
macules, usually less than 5 mm in diameter. They multiply and become darker with sun 
exposure. Increased melanin is seen in the basal layer of the epidermis without any increase in 
the number of melanocytes, and without elongation of the rete ridges. No treatment is 
necessary (Weller R et al. 2011). In some cases, the appearance of ephelides is a genetic trait.  
They are usually removed for cosmetic reasons using different methods, but good results are 
accomplished using QSRL laser with prior local anesthesia in a form of cream (EMLA, 
lidocain 2,5% and prilocain 2,5% in oil in water emulsion) during approximately one hour 
with occlusion. There are sometimes transitory hypopigmentations present, and photo 
protection is mandatory after the treatment (Bukvić Mokos Z 2006). The absence of purpura 
after the treatment with QSRL (694 nm) and alexandrite (755 nm) laser makes their use 
preferable when compared with green light lasers (Gravelink JM et al. 1993 & Nehal KS et al. 
1996). 
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4.1.3. Café au lait spots 
Café au lait spots are benign pigmented skin lesions that develop due to an increase in 
melanin content. The color varies from light to dark brown, and borders are either smooth or 
irregular. They are characterized histologically by an augmentation of pigmentation in the 
basal layer of epidermis. They can be seen in 20% of healthy people, or are associated with 
neurofibromatosis (in 95% of people with neurofibromatosis type 1), McCune-Albright 
syndrome, tuberous sclerosis and Fanconi anemia. 
Café au lait spots respond variably to laser therapy and recur in as many as 50% of patients. 
Repeated treatments over a long period (several months or even years) are needed to achieve 
maximal clearing of the lesion. Repigmentation occurs from adjacent untreated melanocytes; 
therefore, the entire lesion should be treated at each session (Bukvić Mokos Z et al. 2010 & 
Stratiagos AJ et al. 2000 & Alster TS Lupton JR 2001). 
 
4.1.4. Seborrheic keratoses 
Seborrheic keratoses are common benign epidermal tumors, unrelated to sebaceous 
glands. They usually arise after the age of 50 on the face and trunk, often are multiple, but 
may be single. The appearance varies as flat, raised, filliform or pedunculated, color from 
yellow to black. In most cases the cause is unknown, but multiple lesions may be inherited in 
autosomal dominant manner, may follow an inflammatory dermatosis, or rarely may be 
associated with internal neoplasm (Leser-Trélat sign). Lesions may multiply with age, but 
remain benign (Weller R 2011). They can be removed for cosmetic reasons with curette under 
the local anesthetic, criotherapy or laser therapy. Treatment with QRSL or QS Nd:YAG laser 
systems is effective in removing the lesions, although after the treatment, transitory 
pigmentary alterations are common (Grekin RC 1993).  
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4.2. Dermal pigmented lesions 
4.2.1. Melanocytic nevi 
 Melanocytic nevi (moles) are localized benign tumors of melanocytes. The cause is 
unknown, but genetic factor is likely in many families, working together with excessive 
sun exposure during childhood. With the exception of congenital melanocytic nevi, most 
appear in early childhood, with a sharp increase in numbers during adolescence and after 
severe burns. Further crops may appear during pregnancy, estrogen therapy, flare-ups of 
lupus erythematosus, or rarely after cytotoxic therapy and immunosuppression (Weller R 
2011).  
The use of pigment-specific lasers to remove congenital and acquired melanocytic nevi 
remains controversial. Around five percent of people with a large congenital nevus are at 
risk of developing a melanoma. Even though a laser could destroy all the melanocytic 
cells, it may enhance the likelihood of neoplastic change in the remaining nevus cells. This 
hypothesis is also explained by the fact that laser destroys the protective pigment, making 
the remaining cells an easier target for the UV light radiation (Rosenbach A et al. 1997). It 
is necessary to emphasize that the primary treatment of choice for nevus removal is 
surgical excision followed by histopathologic examination. Laser therapy has been 
reserved for the lesions located at cosmetically or functionally sensitive areas where 
surgical excision might leave a disfiguring scar (Bukvić Mokos Z et al. 2010).  
Acquired melanocytic nevi should always be carefully evaluated clinically before laser 
treatment. Benign junctional melanocytic nevi show good therapeutic response to 
relatively short wavelengths, while deeper compound or dermal types of melanocytic nevi 
require longer wavelengths, higher fluencies and longer pulsewidths, and still tend to recur 
(Stratigos AJ et al. 2000 & Alster TS Lupton JR 2001 & Hague JS Lanigan SW 2008 and 
Suzuki H Anderson RR 2005). Still, laser treatment is associated with several problems: 
variable response, permanent hypopigmentation, local scarring and rarely achieved 
complete clinical response. Additionally, incomplete nevus removal may be followed by 
pseudomelanoma development, and early melanoma lesions can be easily mistaken for 
benign spots (Bukvić Mokos Z et al. 2010). 
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4.2.2. Blue nevi 
Blue nevi, so-called because of their striking gray-blue color; usually appear in childhood 
and adolescence as solitary lesions on the limbs, buttocks and lower back (Weller R 2011). 
They can be successfully removed by longer wavelength red-light lasers. However, since 
the differential diagnosis includes melanoma, surgical excision is the safest method in this 
indication (Milgraum SS et al. 1995). 
 
4.2.3. Drug induced hyperpigmentation 
 Drug induced hyperpigmentation should be in a differential diagnosis in a patient 
presenting with unexplained pigmented lesion, especially when on multidrug regimen. It can 
be induced by various drugs, most commonly amiodarone and minocycline (Alster TS Lupton 
JR 2001).  
Patients taking amiodarone may develop a phototoxic exanthema limited to sun exposed 
areas, or a blue-gray dermal melanosis – ceruloderma, which develops due to deposition of 
melanin and lipofuscin contained in the macrophages and the endothelial cells in the dermis. 
This pigmentation is reversible within a year when the drug is stopped (Wolff K Johnson RA 
2009). The treatment is successful using QRSL with disappearance of lesions after one 
session (Karrer S et al. 1999). 
The skin hyperpigmentation seen with minocycline doesn’t occur due to melanin deposits, but 
an iron containing brown pigment located in dermal macrophages usually on extensor 
surfaces of the legs, dorsa of the feet and around the eyes. After stopping of the drug, the 
discoloration will disappear within a year (Wolff K Johnson RA 2009). Both the QSRL and 
1064nm QS Nd:YAG lasers have been reported to be very effective in cases where 
pigmentary reaction is profoundly disfiguring (Zollner et al. 1996 & Knoell KA et al. 1996). 
 
4.2.4. Nevi of Ota and Ito 
 Nevi of Ota and Ito are colored skin markings of slate-brown or blue/grey coloring. 
They are unusual birthmarks in which the melanocytes are found to be in the dermis instead 
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of the epidermis. They are most commonly found in Asian populations with estimation that 
0.2-0.6% of Japanese people have nevi of Ota which are much more common than nevi of Ito. 
They are present at birth in 50% of cases but may appear during adolescence or adult life. The 
difference between the two is in a location. Naevus of Ota is on the forehead and face around 
the eye area, while naevus of Ito is on the shoulder and upper arm area. Laser treatment by 
1064 nm Q switched Nd:YAG or QS ruby laser is more effective in light skinned individuals 
than in those with dark skin. Multiple treatments are necessary, often with a combination of 
devices. Unfortunately, recurrence is common after laser clearance, sometimes resulting in a 
darker hue. Q-switched Alexandrite was found to be effective in the treatment of nevus of Ota 
but limited results were accomplished for the nevus of Ito (Wang HW et al. 2006). 
 
4.3. Mixed epidermal/dermal pigmented lesions 
4.3.1. Becker’s nevus 
 Becker’s nevus usually appears in boys in puberty, unilaterally on the shoulder, 
pectoral region or back, in a form of sharply demarcated hyperpigmentation with 
hypertrichosis. Sometimes, these changes may be accompanied with hamartoma of the 
smooth muscle (Bukvić Mokos Z 2006). Patients should be evaluated for soft tissue and bone 
abnormalities, as those can occasionally be associated with this condition. Treatment is 
usually done by a combination of QSRL, which damages superficial pigmented cells of the 
nevus, although a significant amount of pigment persists in the adnexal structures, and longer 
pulse pigment specific laser, which removes the hairs of Becker’s nevus (Alster TS 2000 & 
Kilmer SL et al. 1994). Complete removal is difficult with a high rate of recurrence associated 
with hypopigmentation and incomplete removal. 
 
4.3.2. Postinflammatory hyperpigmentations 
Postinflammatory hyperpigmentations present after numerous inflammatory dermatoses, 
especially in patients with darker skin. In these changes, there is a rupture of epidermal-
dermal border, with the location of melanin in the dermal macrophages. Postinflammatory 
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hyperpigmentations are especially resistant to therapy, with only slight improvement after 
multiple sessions with QSRL (Bukvić Mokos Z 2006). 
 
4.3.3. Melasma 
Melasma is an acquired, symmetrical hypermelanoses occurring on the sun-exposed skin, 
especially the face. The areas of increased pigmentation are well defined and their edges may 
be scalloped. The condition is much more common in women, affects all races, but is more 
prevalent among dark-skinned individuals. The hypermelanoses becomes darker after 
exposure to the sun. There are many causes, including sunlight, pregnancy, estrogens, oral 
contraceptives, scented cosmetics, thyroid dysfunction and photosensitizing drugs. Treatment 
is unsatisfactory. Some find treatment with bleaching agents that contain hydroquinone 
helpful (Weller R 2011). Laser treatment produces variable results, with sometimes even 
worsening of the condition (Stratigos AJ 2000 & Alster TS and Lupton JR 2001 & Taylor CR 
Anderson RR 1994). 
 
4.3.4. Nevus spilus 
 Nevus spilus is a typical café au lait macule with multiple darkly pigmented speckles 
within it. These often represent either compound or junctional nevi. There are several reports 
of dysplastic nevi developing within nevus spilus and of melanoma arising within these 
lesions, which is the reason why it is recommended to make biopsy in case of any atypical 
appearing lesion within nevus spilus (Bukvić Mokos Z et al. 2010). Several session with 510 
nm PLDL, 532 nm QS Nd:YAG, QRSL or QS alexandrite laser are needed in six to eight 
weeks intervals to progressively remove the unwanted pigment (Goldberg DJ 1999 & Kilmer 
SL and Alster TS 1996).  
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4.4. TATOOS 
 
 With the increase of prevalence of tattoos in the past years, there is also an increased 
need for their removal. In the past, laser tattoo removal involved the non-specific ablation of 
the skin overlying the tattoo, resulting in removal, but also pigment alteration and scarring.  
Currently, tattoo removal is performed primarily via selective photothermolysis, using the 
tattoo ink as a chromophore for the laser. Each color of the ink is absorbed by a different 
wavelength of light, and hence the more ink colors in the tattoo, the more difficult it is to 
remove. Cosmetic tattoos are usually a blend of several different inks, rendering them 
extremely challenging to remove with laser. Professional tattoos typically place ink in the 
mid-dermis, requiring a device that can penetrate to this depth in order to achieve adequate 
treatment. Amateur tattoos typically use less ink and placement is more superficial, making 
them easier to remove (Baumann L 2009). 
 The removal of tattoo ink must be achieved with a very short pulse-width system in 
the nanosecond range, just as in removal of melanosomes from the skin. These systems are Q-
switched laser devices – ruby, alexandrite, and Nd:YAG. The ruby (694 nm) was the first one 
available and is good for the removal of blue and black pigments (Taylor CR et al. 1990). The 
alexandrite (755 nm) is also effective at removing blue and black pigments, but in addition, 
has the unique ability to remove green, which is historically one of the most difficult colors to 
eliminate (Fitzpatrick RE Goldman MP 1994). The ND:YAG (1064 nm) is used for the basic 
black ink, especially in professional tattoos due to its capacity for deep penetration. The 
frequency doubled Nd:YAG (532 nm) can be used for red pigments. 
 The mechanism of removing tattoo is photoacoustic effect which leads to rupture of 
the pigment containing cells – perivascular fibroblasts, macrophages and mastocytes. As a 
result, there is accumulation of neutrophiles, and re-deposition of ink into fibroblasts, 
macrophages and mastocytes, with the part of the ink being removed by the lymph. 
Adittionally, part of the pigment is removed by transepidermal migration. Older tattoos are 
more easily removed than the new ones, and distally placed tattoos are less responsive to 
treatment, probably due to the effect of lymphatic system (Bukvić Mokos Z 2006). 
Generally, a combination of lasers is needed for successful removal of a tattoo, although 
residual ink or shadow may persist despite numerous treatment sessions. For the removal of 
professional tattoos, eight to twelve treatments spaced at least 6 weeks apart are required, 
while for amateur tattoos, three to five treatments are generally effective (Bernstein EF 2006). 
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In patients with darker skin types, tattoo removal may result in scarring or dyspigmentation. 
Moist wound healing via topical emollient creams and a dressing are recommended for all 
patients for 1 to 2 weeks after laser treatment. Straying from this regimen will increase the 
risk of postinflammatory changes and scarring, and delay additional treatments (Baumann L 
2009).  
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5. LASER HAIR REMOVAL 
 Mechanism of laser or light-assisted hair removal is based on the principle of selective 
photothermolysis with wavelengths of light well absorbed by follicular melanin and pulse 
durations that selectively thermally damage the target without damaging surrounding tissue 
(Dierickx C et al.1998). 
 The stem cells responsible for the hair growth cycle are located at the outermost cell 
layer of the hair follicle and do not contain melanin pigment. Thermal injury to the follicular 
stem cells causes permanent hair loss. Therefore, thermal diffusion from the hair absorbing 
laser light must reach the follicular stem cells. Nanosecond or microsecond pulsed light 
cannot be used for permanent hair removal, because it can destroy melanin-containing hair, 
but cannot destroy follicular stem cells which have no melanin. Therefore, pulse-width of 
lasers available for hair removal must be longer than pigment-specific lasers, and millisecond 
pulse-width lasers are chosen for hair removal (Watanabe S 2008).  
 The choice of laser depends on the hair color and texture, as well as the patient's skin 
color. The strongest absorption of light by melanin is at the shorter wavelengths, which 
penetrate less deeply, so some do not effectively reach the hair bulb. For this reason, the ruby 
laser (694 nm) is no longer used. Darker and coarser hair absorbs more light energy from the 
laser device, and hence can be removed at even longer wavelengths. However, melanin in the 
skin competes with the melanin in the hair for laser absorption. The darker the skin color, the 
more difficulty laser has in distinguishing the hair melanin from skin melanin and the more 
difficult the treatment. 
 Cooling is critical for protection of epidermis in hair removal. Without cooling, the 
melanin in the skin would first absorb the laser light and burn the skin as opposed to removing 
hair. When used without cooling, many of the wavelengths used for hair removal, can be 
actually used for epidermal pigment removal. 
 In the book Cosmetic Dermatology (Baumann L 2009), the author presents three most 
important lasers used nowadays used for hair removal. 
The alexandrite laser (755 nm) is the shortest wavelength removal system used. Due to high 
absorption of light by melanin at this wavelength, the alexandrite is able to remove lightly 
pigmented hairs from light skin. It should be used with extreme caution in darker skin types 
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due to possible hypopigmentation and postinflammatory hyperpigmentation. There are also 
reports of paradoxical hypertrichosis after laser hair removal with alexandrite (Alajlan A et al. 
2005).   
The diode (800 and 810 nm) laser can be used on all skin types, while the best results are 
achieved on darker hair. This is the most commonly used laser for hair removal nowadays.  
The Nd:YAG (1064nm) operates at wavelength minimally absorbed by melanin, which makes 
this laser effective for removal of dark, coarse hairs. It is the safest system for hair removal in 
darker skin types, although in comparison to other lasers, in one study it was found to be more 
painful and less efficacious (Rao J and Goldman MP 2005). 
 Prior the treatment, skin should not be tanned, damaged, or show any signs of 
infection. Test spots are performed 2 weeks before the full treatment. Immediately after the 
treatment, the area should exhibit follicular edema and erythema which is the normal response 
to laser heating of the follicle. To avoid postinflammatory changes in darker skin types, 
topical steroid is often used for 5 days. Complete removal can take from three to ten sessions 
spaced 1 month apart, depending on the hair, treatment area and the patient’s skin type. Sun 
protection is critical both before and after laser hair removal (Baumann L 2009).  
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6. VASCULAR LASERS 
 
 In the treatment of vascular lesions, the targets of laser treatment are not red blood 
cells, but endothelium and vessel walls. The laser treatment of vascular lesions is based on 
selective absorption by blood with thermal injury to the vessel wall. Therefore, the pulse-
width of the vascular-specific lasers must be longer (microsecond-domain) than that of 
pigment specific lasers. In general, a pulse-width of 450 µs is chosen for the treatment of port 
wine stain. Longer pulse-width lasers are better for the treatment of vascular lesions with 
thicker vessels, but shorter pulse-width ones are better for those with thinner vessels. Since 
lasers with microsecond-domain pulse-width have a higher possibility to cause scarring than 
those with nanosecond domain pulse-width, cooling devices are needed for protection of the 
skin surface from thermal injury by laser irradiation (Watanabe S 2008). 
 The chromophore for vascular lesions is oxyhemoglobin. The peak absorption by 
oxyhemoglobin lies somewhere between 500 and 600 nm. Most of the lasers used for vascular 
lesions emit light with wavelengths in this range, but longer wavelengths can also be used 
because they penetrate deeper, owing to less scattering by collagen. The oxyhemoglobin 
target must absorb the light, generate heat, and coagulate the vessel, all without damaging the 
surrounding tissue. The most popular systems used today for vascular lesions are the pulsed 
dye laser PDL (585 nm), long pulsed-dye laser (595 nm), the potassiumtitanylphosphate KTP 
(532 nm) and Nd:YAG (1064 nm) neodymiumdoped yttrium aluminium garnet.  
PDL devices are effective for telangiectasias on the face, neck, and chest, but perform less 
well on the body, which is related to the short wavelength and superficial penetration of the 
laser. They are used for vascular malformations in both adults and children, including 
hemangiomas, port wine stains and lymphangiomas. PDLs available today come equipped 
with cryogen cooling, various spot sizes, and adjustable pulse durations that should be 
adjusted to the vessel diameter and its thermal relaxation time. The larger the diameter of the 
vessel, the longer the optimal pulse width should be, because very short pulse widths lead to 
rupture of the vessel and resultant purpura. Side effects in addition to purpura include 
blistering, postinflammatory pigment alteration (PIPA) caused by the cryogen spray, as well 
as scarring from overly aggressive fluences. Lesions on the chest and neck should always be 
treated with lower energies than those on the face (Baumann L 2009). 
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In less than 1% there are side effects of PDL treatment such as ulceration with scarring and 
hypopigmentation. After the treatment, local ecchymoses, swelling and discomfort can occur, 
but the application of cooling gel or ice packs will minimize discomfort. Local erythema or 
purpura may persist for 7 to 14 days, sometimes followed by hypopigmentation or 
hyperpigmentation and atrophic scarring. High SPF creams and emollients should be used 
until clearing of the purpura. PDL therapy can be repeated at 8-12 week intervals, and several 
treatments are frequently required (Barčot Z and Župančić B 2010). 
The KTP laser (532 nm) is highly absorbed by oxyhemoglobin, and has proven to be at least 
as effective for facial telangiectasias as the PDLs (Uebelhoer NS et al. 2007). It can operate in 
a range of longer pulse widths, resulting in no purpura, but its shortcomings are related to its 
shorter wavelength and lack of penetration. KTP is the most effective for treatment of very 
superficial vessels, but the treatment of darker skin should be performed with caution because 
532 nm wavelength is as well absorbed by melanin. 
 Longer wavelength lasers allow for deeper penetration and are excellent choice for 
lower extremities. They are also particularly useful for high flow vessels on the face 
(Baumann L 2009). 
 Lesions amenable to laser treatment with a vascular wavelength include hemangiomas, 
nevus flammeus (port wine stains), lymphangiomas, venous lakes, cherry angiomas, 
telangiectasias, spider veins, poikiloderma of Civatte, and erythema from rosacea (Baumann 
L 2009). These lesions are removed after several treatments, usually 4 to 5 weeks apart 
(Railan D et al. 2006). In most cases, treatments are very efficient and well tolerated, without 
the need for anesthesia (Dover JS Arndt KA 2000). The exceptions are treatments of nevus 
flammeus and hemangiomas in children, which frequently require general anesthesia (Tanzi 
EI et al. 2003). 
 Taking into account a great number of vascular changes and a limited frame of this 
paper, in the following section the analysis will be focused on the most frequently treated 
vascular changes by lasers. 
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6.1. Congenital vascular changes  
 
 Almost all congenital vascular abnormalities affect the skin and are evident from birth 
or become so during the first few weeks of life. The two most common types of vascular 
birthmarks, hemangiomas and vascular malformations, may appear to be very similar but their 
course and treatment are different (Barčot Z  and Župančić B 2010). 
Prior to formal laser therapy, a test treatment should be considered with evaluation of patients 
in 2-3 months. During each application, overlapping of pulses (25-30%) is done with PDL. At 
least transiently immediate purpura is desired, and indicates appropriate laser energy settings 
(Eifert S 2000). 
 
 
6.1.1. Hemangiomas of infancy 
 
Hemangiomas of infancy are the most common benign tumors of childhood, 
composed of proliferating endothelial tumor cells. They usually manifest as cutaneous 
birthmarks, characterized by early, rapid proliferation and regression in the majority of cases 
(Lin RL Schwartz RA 2006). They present in 3% of newborns, as a result of abnormal 
changes in angiogenesis, which leads to over-proliferation of vascular entities (Geronemus 
RG 1995). Most of them develop sporadically, but may also be a part of larger syndromes 
associated with high rates of life-changing morbidity and mortality. Their frequency tends to 
be higher in infants who are preterm, weighing less than 1500 g, with females being more 
affected than males (No D et al. 2003). The most common location is head and neck (59%), 
followed by the trunk (24%), lower extremities (10%), and upper extremities (7%) (Chiller 
KG et al.2002).  Although majority of hemangiomas begin to slowly involute by 1 year of 
age, complete resolution often takes 5 to 12 years. Regression typically occurs in 50% of 
patients by age 5, in 70% by age 7, and in 90% by age 9 (Kapur N et al. 2002).  
 The goals of management are to prevent or avoid life or function threatening 
complications, to prevent permanent disfigurement, to minimize the psychological impact on 
the patient and parents, to avoid aggressive or scarring treatments, and to avoid/treat 
ulceration to minimize pain or scarring (Iyer S Fitzpatrick RE 2005). The selection of optimal 
laser therapy for hemangiomas depends strongly on the evolutionary stage of the lesion, 
because early lesions or those in the late evolutionary phase tend to respond better.  
21 
 
 Treatment parameters of PDL are generally 585 nm, 0,5-1,5 ms, 5 to 7 J/cm
2
 with 
epidermal cooling. For proliferative lesions, treatments are spaced at 2-3 weeks intervals and 
at 4-6 weeks for nonproliferative lesions. However, PDL is limited by its depth of penetration, 
and is ineffective for deep hemangiomas (Barčot Z and Župančić B 2010). Lesions up to 3 
mm in depth can usually be completely removed, while lesions deeper than 3 mm are more 
resistant to PDL treatment. 
For the deeper situated lesions, lasers of choice are continuous wave Nd:YAG, newer long-
pulsed dye lasers (595 nm, 1,5 ms) or pulsed Nd:YAG that have more vascular selective 
tissue reaction (Čeović R 2006).  
 
 
6.1.2. Vascular malformations 
 
Vascular malformations are always present from birth even though they might not be 
apparent, never disappear, and often grow during person’s lifetime (Chiller KG et al. 2002). 
Two thirds are venous, and unlike hemangiomas don’t have a growth cycle and spontaneous 
regression, but persist throughout lifetime, grow slowly, sometimes in response to injury or 
changes in blood and lymph pressure. They progressively produce ectasia of vascular 
structures, increasing the diameter of vessels without increasing their number. While 
expansion of hemangiomas is due to hyperplasia, in vascular malformations it is hypertrophy 
(Barčot Z and Župančić B 2010). The diagnosis of vascular tumor is based on history and 
physical examination alone in about 95% of cases (Frieden IJ et al. 1997), but ultrasound with 
Doppler is the most cost-effective imaging technique. Venular malformations can be divided 
into midline malformations and traditional venular malformations known as port wine stains, 
telangiectatic nevus, or nevus flammeus (Barčot Z and Župančić B 2010).  
 
 
6.2. Acquired vascular changes  
 
6.2.1. Telangiectases 
 
Telangiectases are permanently dilated and visible small vessels in the skin. They 
appear as linear, punctuate, or stellate crimson-purple markings anywhere on the body, but 
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most frequently on cheeks, beard, nose or legs. They are usually just a cosmetic defect as a 
consequence of chronic sun exposure, radiation, or corticosteroid therapy, but can also be a 
part of clinical picture of different diseases (Ataxia telangiectasia, Rendu-Osler-Weber, 
CREST syndrome, Xeroderma pigmentosum, Lupus erythematosus) (Tan OT et al. 1989). 
Treatment of telangiectases on the face is one of the most frequently performed laser 
procedures using PDL, KTP laser, or pulse Nd:YAG laser. With newer PDL, it is possible to 
avoid post treatment purpura, often seen in the past. KTP lasers do not cause purpura, but the 
degree of removal is lower than with PDL (Čeović R 2006). 
 
 
6.2.2. Venous lake 
A venous lake is a solitary, compressible, violaceous, 0.2 to 1 cm papule commonly 
found on sun-exposed surfaces of the vermilion border of the lip, face and ears in elderly. 
Treatment may be requested for cosmetic reasons using argon and KTP laser when blood 
vessels have diameter of less than 1,2 mm (Dehkor PS 2006). Nd:YAG laser is shown to be 
highly effective, with a clearance rate of 94% following a single treatment (Bekhor P 2006). 
 
6.2.3. Cherry angiomas 
Cherry angiomas are benign small bright red papules, usually multiple most frequently 
seen on the trunks of middle aged and elderly. Treatment is by flashlamp PDL or KTP laser 
(Landthaler M and Hohenleutner U 2006).  
 
6.2.4. Pyogenic granulomas 
Pyogenic granulomas are common benign acquired hemangiomas often seen in 
children and young adults. They develop at sites of trauma, over the course of a few weeks, as 
bright red raised, sometimes pedunculated and rapsberry-like lesions which bleed easily 
(Weller R et al. 2011). Smaller pyogenic granulomas are treated by argon or KTP laser, and 
bigger ones by CO2 laser (Landthaler M Hohenleutner U 2006). 
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7. RESURFACING LASERS 
 
 Over the last 20 years there have been major advances in the field of nonsurgical skin 
rejuvenation. With advances in laser technology it is now possible to reduce, and in some 
cases remove, facial wrinkles, acne scars and other facial scars, and a variety of skin growths 
and blemishes with minimal disruption and downtime for the patient. 
However, laser „resurfacing“ is considered to be the most complicated corrective laser 
operation, which demands elaborate preoperative and postoperative procedure (Kostović K 
2006). One of the crucial parts of treatment is patient selection. An ideal candidate is patient 
of any age in good health, with fair skin type, who has photodamaged skin and moderate 
postoperative expectations (Alister TS 1999). It is important to take detailed anamnesis in 
order to establish the capacity of wound healing, as well as possible conditions that could 
have an impact on it: diet, anemia, immunodeficiency, connective tissue disorders, and 
isotretinoin therapy (Kostović K 2006). 
  Absolute contraindications to the procedure include a history of keloids and 
connective tissue disease, and history of radiation therapy or scleroderma due to reduction in 
adnexal structures that serve as a pool of stem cells for reepithelialization. Other 
contraindications are recent (within one year) isotretinoin therapy that can result in atypical 
scarring, unrealistic expectations, and epilepsy. Resurfacing performed soon after a face-lift 
procedure or blepharoplasty increases the risk of skin necrosis, ectropion and scarring due to 
undermined vascularization. In order to improve the outcome of laser resurfacing preoperative 
regimens, local hydroquinone and topical tretinoin are used. In all patients, prophylactic oral 
antiviral therapy and antibiotics should be prescribed (Štulhofer Buzina D et al. 2010).  
 Anesthesia can be achieved by local anesthetics, regional nerves block, or IV 
anesthesia. After the procedure, wound care can be performed using the opened or closed 
technique. Possible early complications are infection, contact dermatitis, acne and milia. Late 
complications include postinflammatory hyperpigmentation - especially in darker skin, 
relative hypopigmentation, permanent hypopigmentation which appears in 5-12 months after 
laser resurfacing and is more common in light skin individuals, erythema that lasts longer than 
3 months, and scarring (Kostović K 2006). 
24 
 
7.1. Ablative resurfacing 
 Ablative resurfacing involves wounding the skin to the dermal level, thereby removing 
photodamaged areas of the epidermis. Dermal wound healing stimulates collagen production. 
Ultimately, ultrastructural remodeling results in rejuvenated skin. Resurfacing occurs at the 3 
levels: superficial (wounds from the stratum corneum through the papillary dermis), medium 
(wounds of the upper reticular dermis) and deep (wounds of the midreticular dermis). Options 
for ablative resurfacing include dermabrasion, chemical peeling, and laser surgery (Tanna N 
2014). The popularity of dermabrasion has diminished because of an increased prevalence and 
awareness of blood-borne pathogens, as well as technical difficulties in maintaining the 
proper depth. While superficial peeling agents such as glycolic acid remain popular, they do 
not penetrate the dermis. A medium-to-deep chemical peel must be used to perform ablative 
resurfacing.  
 Laser skin resurfacing (LSR) has become an important component of rejuvenation 
surgery. Although this technology is relatively new, its benefits are clear. The laser allows for 
precise control of ablation depth, and it permits the surgeon to vary these depths as needed. In 
addition to such precision, LSR causes favorable heating of the dermis, which tightens 
collagen fibers and stimulates neocollagen secretion by fibroblasts (Tanna N 2014). 
Resurfacing using Er:YAG laser is an optimal method for removal of mild to moderate 
superficial wrinkles and scars, while pulsed CO2 laser is used for removal of deeper scars and 
wrinkles (Štulhofer Buzina D 2006). 
With the rapid vaporization of tissue with any ablative laser comes tissue tightening and 
smoothening of the skin, which is not achieved with most other nonablative laser systems 
(Baumann L 2009). 
 
7.1.1. CO2 laser 
 Ablative resurfacing has historically been performed using the CO2 laser. Since its 
introduction in 1968, it’s been used for the treatment of acne scars, rhytides, actinic chelitis 
and other symptoms of photoaging (Baumann L 2009). At a wavelength of 10,600 nm, in far 
infrared spectrum, energy is preferentially absorbed by intracellular and extracellular water 
creating rapid heating and vaporization of tissue. New high energy short pulsed CO2 lasers 
and scanned cwCO2 produce relatively superficial tissue vaporization and minimize deeper 
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thermal injury that is associated with undesirable side effects like scarring and 
hypopigmentations (Štulhofer Buzina D et al. 2010).  
 The laser penetrates approximately 30 µm within the skin. Thermal injury is prevented 
when the laser pulse width is less than the thermal relaxation time of the tissue. The critical 
pulse width is less than 1 millisecond. The first pass of the CO2 laser causes approximately 
50-70 µm of ablation. Since the resulting layer of thermal necrosis has less tissue water than 
the uninjured skin, successive passes result in less tissue vaporization. With each pass, 
however, the total depth of thermal necrosis increases slightly, but does not exceed a depth of 
100 µm if the pulse width is kept at less than 1 millisecond (Tanna N 2014). 
 The pulsed CO2 resurfacing allows for precise depth of ablation and controlled thermal 
damage. It appears that thermal injury below the vaporization zone induces desiccation and 
collagen shrinkage, which serves as a scaffold for the formation and deposition of new 
collagen. Immunohistochemistry evaluations demonstrated up-regulation of procollagens I 
and II, interleukin 1-β, TNF-α, TGF-β1 and matrix. The CO2 laser resurfacing is a painful 
method due to tissue heating, so topical anesthetic agents should be used for treatment of 
individual cosmetic units, with adding of systemic agents for larger areas such as the whole 
face (Štulhofer Buzina D et al. 2010). 
 After the treatment, edema and exudation occur, most severely during second and third 
postoperative days. The application of bio-occlusive dressings will minimize pain and speed 
up reepithelization which is usually completed in 10-14 days. Marked erythema can persist up 
to 1 year, and sun avoidance is mandatory. The most common adverse effects are 
dyspigmentations in the form of post-inflammatory hyperpigmentations in dark-skinned 
patients, and more serious late hypopigmentations which occur 6-12 months after the 
treatment. Other possible complications include eczema, scarring and skin infections 
(Štulhofer Buzina D et al. 2010).  
 
7.1.2. Er:YAG laser 
 The erbium:yttrium-aluminum-garnet (Er:YAG) offers precise tissue ablation with 
minimal thermal damage. It emits a wavelength of 2940 nm and is even more highly absorbed 
by water (peak water absorption is at 3000 nm), which results in a more superficial depth 
when compared to the CO2 laser and less collateral thermal damage (Baumann L 2009). 
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Pulsewidths of 200-350 microseconds result in thermal necrosis of less than 10 µm in depth. 
Unlike the CO2 laser, with successive passes of the Er:YAG laser, the thermal injury depth 
remains stable. Additionally, stacking Er:YAG pulses slightly reduces the ablative efficiency. 
With the CO2 laser, the ablative efficiency decreases with successive passes (Tanna N 2014). 
During Er:YAG laser ablation, delivered energy is absorbed into heat, but escapes as steam 
decreasing thermal injury to the surrounding tissue. Hence, no visible contraction of dermal 
collagen fibers is observed (Tanzi EL et al. 2003). This may be a reason for moderate results 
after Er:YAG resurfacing in comparison with CO2 treatment, but also makes it a safer method 
especially suitable for mild to moderate rhytids and photodamaged skin (Tenzel EL and 
Alister TS 2003). 
 Patient selection, preoperative and postoperative regimens are similar to the CO2, but 
with the safer profile of Er:YAG in darker skin types and reduced risk of pigmentary changes. 
Post-treatment swelling may persist for 10-14 days, but post-inflammatory erythema resolves 
in 6 weeks to 6 months, depending on the depth of resurfacing. Major benefits of Er:YAG are 
lower morbidity, rapid reepithelization, faster resolution of post-treatment erythema and less 
serious complications when compared to CO2 treatment (Štulhofer Buzina D et al. 2010). 
 
7.2. Nonablative resurfacing 
 Nonablative lasers developed as an alternative to traditional ablative resurfacing. 
Nonablative methods induce careful heating of deep dermal layers while protecting the 
epidermis by cooling (Kelly KM et al. 1999). Nonablative nonfractionated lasers produce a 
gentler effect on the skin, inducing controlled tissue injury in the dermis and stimulating 
dermal remodeling and collagen production (Preissig J, et al. 2012).  
Although these devices do not produce the same degree of improvement as traditional CO2 or 
Er:YAG resurfacing techniques, they are an excellent alternative for people seeking gradual 
aesthetic improvement with minimal downtime and side-effects. The potential damaging risks 
associated with nonablative lasers are significantly lower compared to ablative lasers (Ciocon 
D et al. 2011), and patients experience as little as a few hours of erythema with no scaling or 
peeling of the skin. Patients with darker skin tones are also candidates for nonablative lasers 
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as they do not induce the abnormal pigmentation that often arises with ablative laser use on 
darker skin (Newman JB et al. 2000).  
 The long-pulsed 1320-nm Nd:YAG laser was the first nonablative laser to reach the 
commercial market. It functions by avoiding damage to the epidermis and instead targeting 
the dermal layers to stimulate new collagen growth. The water in the skin absorbs the 1320-
nm wavelength in particular, creating an even distribution of energy without damaging 
melanin or hemoglobin. As such, this laser is effective on all skin types without producing 
changes in pigment (Preissig J, et al. 2012). The laser accelerates the productive capacity and 
vitality of fibroblasts, as seen in its promotion of the two major secretory factors they 
produce: basic fibroblast growth factor (bFGF) and inhibiting transforming growth factor β1 
(TGF-β1) (Zhenxiao Z et al. 2011). The laser actively reverses visible and histopathologic 
signs of skin aging as it stimulates collagen types I, III, and VII, and tropoelastin production 
(El-Domyati M et al. 2011). The laser has been noted as safe and effective in the treatment of 
acne and related scarring by shrinking sebaceous glands and minimizing sebum production 
which prevents future acne lesions (Yaghmai D et al. 2005). 
 The 1319-nm pulsed energy laser is a member of the mid-infrared laser class, which is 
effective at treating fine facial wrinkles. It resurfaces the skin to improve the appearance of 
wrinkles, acne and related scarring, skin tone, and texture. Like other nonablative lasers, the 
1319-nm pulsed energy laser thermally targets the fibroblasts that reside in the dermal layer to 
stimulate production of collagen (Bogle MA 2008). These lasers are not beneficial for treating 
pigment discolorations or vascular abnormalities, although they are designed to safely treat all 
skin types and shades (Preissig J, et al. 2012). 
 The 1450-nm diode laser is effective for the treatment of facial acne by partially 
damaging sebaceous glands to reduce sebum secretions, as well as for improving the 
appearance of scarring (Friedman PM et al. 2004). It has demonstrated greater scar response 
after treatment than the nonablative 1320-nm Nd:YAG laser by targeting sebaceous glands in 
the upper dermis while sparing the epidermis, reducing downtime (Paithankar DY et al. 
2002).
 
Downtime is minimal and is restricted to temporary erythema, edema, and 
hyperpigmentation after treatments (Tanzi EL et al 2003).  
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7.3. Fractional resurfacing 
 The search for laser rejuvenation alternatives was prompted by the high complication 
rates associated with traditional ablative resurfacing. The concept of fractional resurfacing 
was introduced in 2004 by Manstein et al. Fractional resurfacing produces clinical and 
histologic changes comparable to ablative lasers, but spares most of the skin and is 
characterized by rapid reepithelization and mild side effects just like nonablative resurfacing 
(Štulhofer Buzina D et al. 2010). 
 The term “fractional” refers to treating a portion or fraction of the skin, without 
specification of laser type, spot size or wavelength. By treating only microscopic areas in one 
session, healing time is greatly reduced. Each treated area is surrounded by normal viable skin 
from which migration of keratinocytes occurs. Each treatment spot is termed a microscopic 
treatment zone (MTZ) which heals via migration of the normal surrounding epidermis, as 
opposed to healing via differentiation. Very high energies can be tolerated without bulk 
heating, and epidermal healing is completed within 36 hours. This rapid healing time reduces 
the incidence of infections, pigment alterations, and scarring (Baumann L 2009). The higher 
the density, the closer together the MTZ will be, and the more agressive the treatment. 
Fractional devices come in two varieties: ablative and nonablative (Baumann L 2009). 
 
7.3.1. Ablative fractional lasers 
 The most recent generation of ablative lasers are the fractional ablative lasers, with the 
start of usage around 2007. These lasers have been able to reduce the trauma of the treatment 
and decrease downtime while retaining resurfacing power. They are significantly safer than 
their nonfractionated counterparts, but they still retain a high risk of potential damage in the 
form of scarring, discoloration, and skin infection (Chwalek J and Goldberg DJ 2011). 
The main use of these lasers is for mild skin tightening to battle laxity and rhytides. However, 
they can also treat photodamage, atrophic acne scars, hypopigmented scars, and 
dyspigmentation (Karsai S et al. 2010). Overall, patients can expect moderate down time and 
moderate risk of complications (Preissig J, et al. 2012). 
 Fractional technology was first developed in use with CO2 lasers. Side effects are rarer 
than with nonfractional lasers, and only a few cases of scarring following fractional CO2 
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therapy have been reported (Fife Djet al. 2009). Currently, the main representatives of 
ablative fractional CO2 lasers are the Lumenis UltraPulse Encore, and Fraxel re:pair (Preissig 
J, et al. 2012). 
 Fractional technology can be applied to Er:YAG lasers in the same way that it was 
developed for CO2 lasers. Similar to the comparison between nonfractionated CO2 and 
Er:YAG lasers, the fractionated versions of these two laser types have similar postoperative 
and comparable cosmetic improvement (Preissig J, et al. 2012). 
 
7.3.2. Nonablative fractional lasers 
 The 1410-nm Laser (Solta Fraxel Re:Fine) is nonablative fractional laser designed to 
resurface the skin, reducing the appearance of superficial rhytides. It requires 3 to 5 
treatments to see results with a minimal downtime of 3 to 5 days. The laser is safe in all skin 
types, making it very versatile for a broad spectrum of patients.  
 The 1440 Nd:YAG Laser (Cynosure Affirm and Palomar StarLux) improves the 
appearances of rhytides by microrejuvenation, which is brought about by the induction of 
microcolumns of even heating. The StarLux system employs an additional cooling system to 
improve patient comfort while allowing for a higher power treatment, increasing efficiency. 
The Affirm laser distinguishes itself via its combined apex pulse (CAP) technology, which 
evenly distributes energy across a 300-μm depth, focusing the laser on the desired dermal skin 
layers. This laser also utilizes a cooling system for patient comfort. 
 The 1540-nm (PalomarStarLux 1540 and Palomar Icon) and 1550-nm (Solta Fraxel 
re:store) erbium fiber lasers and the 1927-nm thulium fiber laser (Solta Fraxel re:store DUAL) 
are fractional lasers with ablative and nonablative capabilities that allow them to treat both 
epidermal and dermal skin imperfections. This laser class safely and effectively treats 
epidermal pigmentation, photoaging, melasma, rhytides, atrophic, surgical, and acne-related 
scarring and additional textural imperfections. The fractionated component of the laser allows 
for a spatially precise, regular pattern of columns of tissue injury to be created across the 
treated region, retaining the healing function of the epidermis even while targeting both skin 
layers. Through the fractionated treatment pattern that targets both the dermis and epidermis, 
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these lasers provide the significant skin resurfacing capabilities of an ablative laser while 
retaining the downtime profile of a nonablative laser. However, because the laser can only 
target a fraction of the patient's skin at a time, more treatments are typically required at 2 to 
4 week intervals for the best outcomes (Preissig J, et al. 2012).  
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8. SAFETY MEASURES 
 
 The use of lasers in medical practice has seen great expansion in the past decades. 
However, these devices may also pose a significant hazard. Laser hazards are generally 
divided into beam hazards and nonbeam hazards. Beam hazards inflict ocular and cutaneous 
injury, whereas nonbeam hazards stem from the laser device itself or its interaction with 
materials within the surgical environment. The latter include laser plume hazards and 
electrical hazards inherent in a high voltage system that is a laser device (Dudelzak J and 
Goldberg DJ 2011) 
 
 
8.1. Operator education 
 
 The laser should be operated only by a person who has had training in laser theory, 
techniques of control, and operation of the laser. It is the physician's responsibility to select 
appropriate settings such as power, spot sizes, power density, fluences, operating modes, 
pulse times and accessory operation during each procedure. If the physician designates and 
trains appropriate office personnel to perform the dermatological procedures themselves, he 
should provide instructions on the selection of these settings. The laser should be placed in the 
standby mode whenever it is not being fired, to prevent accidental firing into the field, and 
preclude accidents that could occur if the laser and other footpedals are confused and fired 
during a procedure. 
 
 
8.2. Eye protection 
 
 Ocular injury is a very serious complication arising from the use of a laser. Usually 
operating in the millisecond range of pulse duration, a laser beam cannot effectively be 
shielded by the eyelid blink reflex, which takes a tenth of a second to complete. Furthermore, 
lasers operating in the infrared spectrum do not emit a bright visible light necessary to elicit a 
blink reflex (Friedman NR et al. 1987).
 
The retina is particularly vulnerable to visible and near infrared spectrum optical radiation, 
even that emitted by low powered light devices, as a result of focusing by the ocular refractive 
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media. Retinal injury from optical radiation is in large part related to the absorption by the 
melanin chromophore and, to a lesser degree, xanthophyll and hemoglobin (Barkana Y and 
Belkin M 2000). Depending on the site of retinal injury, the insult may range from 
insignificant in the periphery, to a perceptible deterioration of visual acuity and color 
discrimination in the foveal region. The degree of visual loss is determined by the number of 
lost photoreceptor cells in the fovea. The inflammation and edema resulting from a laser 
injury in the parafoveal region may extend into the fovea, resulting in transient reduction in 
visual acuity that may recover over a period of days to weeks. 
 Certain lasers have the ability to inflict injury on multiple ocular structures. For 
instance, the 1,320 nm neodymium - doped yttrium aluminum garnet (Nd:YAG) laser may 
damage the lens and cornea, as well as the retina. The 755 nm alexandrite, 810 nm diode, and 
the 1,064 nm Nd:YAG lasers endanger the retina and the lens; the 2,940 nm erbium:YAG 
(Er:YAG) laser may damage the lens as well as the cornea (Youker SR and Ammirati CT 
2001). Q-switched near infrared lasers, such as the Q-switched alexandrite and Nd:YAG 
lasers present an even greater threat through a mechanism of photoacoustic waves in addition 
to their thermal effects (Cao LY et al. 2010). Light emitted in very short pulse durations, on 
the order of pico and nanoseconds, results in a photoacoustic laser-tissue interaction, a 
mechanical, rather than a thermal, process that is not pigment dependent. The extremely high 
temperatures (exceeding 10,000°C) generated within the tissue lead to electron stripping, 
resulting in plasma formation, the rapid expansion of which produces tissue damaging 
photoacoustic waves. Retinal injury resulting from photoacoustic waves may culminate in 
perforation (Barkana Y and Belkin M 2000). 
 Ocular protection is, therefore, of outmost importance when operating a laser device. 
Any person that may possibly be exposed to optic radiation must wear appropriate protective 
eyewear, including the laser operator, support staff, patients, and visitors. Protective eyewear 
is chosen based on the wavelengths of light emitted by the laser (Dudelzak J and Goldberg DJ 
2011).  
 Ocular injury may occur not only from a direct laser beam exposure, but also from 
exposure to the light reflected or scattered off glass, glossy metal, or plastic surfaces. Thus, all 
windows and mirrors in the room should be covered with opaque material, all jewelry 
removed, and all instruments anodized, roughened, and ebonized with black fluoropolymeric 
coating (Cao LY et al. 2010). 
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 A warning sign should clearly be displayed on the door of the room where laser 
surgical procedures take place, informing potential visitors and staff of the potential ocular 
hazard inside. 
 
 
8.3. Skin and teeth protection 
 
 Cutaneous injury from a laser beam may be significant and its spectrum may range 
from redness to overt burns and scarring. Lasers may also be a hazard to oral health. Dental 
enamel, in particular, is vulnerable to ultraviolet and infrared light. Thus, lasers operating in 
these wavelengths, including the CO2 and Er:YAG, pose a particular threat. Avoiding oral 
injury can be achieved by keeping the mouth closed or by covering it with a moistened gauze 
or a protective mouthpiece (Pogrel MA et al. 1993). 
 
 
8.4. Plume hazards 
 
 The interaction between a heat producing device and the treated tissue has the 
potential to produce surgical smoke or plume. The evaluation of laser plume as a hazard has 
centered on its mutagenic and carcinogenic capacity, as well as the possible role it may play 
in disease transmission. Plappert et al. in 1999 have found substances released in CO2 laser 
pyrolysis of tissue to be cytotoxic, genotoxic, clastogenic, and mutagenic. Numerous chemical 
substances, some carcinogenic, have been detected in the laser plume, including carbon 
monoxide, hydrogen cyanide, ammonia, formaldehyde, acrolein, toluene, and benzene 
(Barrett WL and Garber SM 2003).  
 Laser procedures utilizing lower irradiance energies carry the risk of liberating cellular 
clumps and red blood cells that may be carried in the laser plume. It is believed that laser 
plume may harbor a greater infectious potential compared to electrosurgical smoke (Sawchuk 
WS et al.1989). The presence of viral particles in the laser plume has been documented in the 
literature. For instance, intact human papillomavirus DNA has been isolated from laser plume 
generated in the CO2 laser treatment of verruca plantaris and respiratory tract papillomatosis. 
Human immunodeficiency virus (HIV) DNA capable of infecting cultured cells has also been 
recovered from a laser plume (Dudelzak J and Goldberg DJ 2011). 
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 Implications of these findings on viral disease transmission have been a subject of 
debate, with emerging evidence supporting infectivity potential. In light of these findings and 
concerns, effective methods should be employed to combat the laser plume hazard. These 
include a smoke evacuator and laser masks. Most surgical masks only filter particles to 
approximately 0.5 μm in size. However, about 77% of particles in the laser plume are 1.1 μm 
or smaller. Therefore, wellfitted high filtration, or laser masks that filter particles larger than 
0.1 μm by means of electrostatically charged synthetic fibers should be employed in place of 
standard surgical masks. These must be frequently changed as condensate moisture eliminates 
their polarity (Youker SR and Ammirati CT 2001). The importance of proper operation of a 
smoke evacuator cannot be overemphasized. The effectiveness of the device is drastically 
reduced from 99 to 50% when the distance from the laser treated site is increased from 1 to 2 
cm (Sawchuk WS et al.1989). 
 
 
8.5. Fire and electrical hazard 
 
 Laser fires may result from ignition of combustible material in the vicinity of a laser 
procedure, resulting in burns. Common sources of fuel include flammable materials used 
during a laser surgical procedure, including gauze, towels or drapes, and respiratory devices, 
including face masks and nasal cannulae. Flammable materials, including makeup and hair 
spray, should be removed prior to a laser procedure. Alcohol should never be utilized to 
prepare a laser surgical field. Caution should be exercised when performing laser procedures 
in hair- bearing areas, as hair can ignite and cause skin burns. In order to mitigate the risk of 
ignition of potentially combustible materials, the prepping with saline of the surgical area and 
supplies, including drapes, gauze, and tubing, is appropriate. A water reservoir, such as a 
bowl or an irrigation syringe, as well as fire extinguisher should always be within easy reach 
during a laser procedure to combat combustion fires on the surgical field. 
Given the high voltage high current electrical nature of lasers, these devices carry a significant 
hazard of electrocution, and should only be maintained and repaired by specially trained and 
authorized personnel (Youker SR and Ammirati CT 2001). 
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9. CONCLUSION 
 
 
 Laser therapy is one of the fastest expanding and most exciting fields in dermatology. 
Although lasers have been used in dermatology for nearly 50 years, only in the last decade 
they gained the widespread acceptance in this field of medicine. Through selective targeting 
of skin chromophores, they revolutionized cosmetic dermatology, providing safe and effective 
means for treating various cutaneous problems. As emphasized in previous chapters of this 
thesis, lasers become the preferred treatment for benign pigmented and vascular lesions, 
tattoos, scars, unwanted hair, and aging skin.  
 The technology and design of lasers continue to evolve, allowing greater control of 
laser parameters and resulting in increased safety and efficacy for patients. With the correctly 
established indications and adequate preoperative and postoperative care of the patient, laser 
therapy nowadays has many advantages in comparison to conventional methods. Still, 
additional research in this area is ongoing and warranted, as are increased regulations in laser 
training and operation, which will ensure the safe and effective treatment of all laser patients. 
 Taking into account the continuing technical advances, as well as the growing number 
of skin problems amenable to laser treatment, lasers are becoming irreplaceable tools of 
modern medicine.  
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